Endothelial dysfunction is an early predictor of cardiovascular events in at-risk patients. It is characterized by impaired endothelium-dependent dilation and is primarily caused by reduced nitric oxide bioavailability secondary to oxidative stress and inflammation. Finding dietary/dietary supplement-oriented approaches to improving endothelial function is of public health interest. A randomized double-blind placebo controlled 4-way crossover study will be conducted to determine if acute consumption of a proprietary polyphenol extract (156 mg / 222 mg / 333 mg) will have a dose dependent response on endothelium-dependent flow-mediated dilation (ED-FMD) in fasting conditions, in comparison to a placebo (maltodextrin) in male smokers (20 - 45 years; n=20).FMD and blood pressure will be assessed at 0 \& 2 hour timepoints following consumption of a single dose of polyphenol extract, accompanying blood samples will be collected to assess a range of endpoints including nitric oxide metabolites, angiotensin and polyphenols metabolites. Endothelium-independent vasodilation will also be measured 2 hours post consumption.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
20
Single dose
Maltodextrin
Human Intervention Studies Unit, Ulster University
Coleraine, Co.Londonderry, United Kingdom
RECRUITINGFlow Mediated Dilation
Acute change in endothelium-dependent flow-mediated dilation
Time frame: Change over 2 hours post dose
Endothelium-independent vasodilation
Acute change in endothelium-independent vasodilation in response to Glyceryl trinitrate (GTN) drug
Time frame: Change after 2 hours post dose
Systolic blood pressure
Measured by brachial cuff
Time frame: Change over 2 hours post dose
Diastolic blood pressure
Measured by brachial cuff
Time frame: Change over 2 hours post dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.